MedPath

1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

Not Applicable
Completed
Conditions
Refractive Ametropia
Interventions
Device: REVIVE Contact Lens
Registration Number
NCT06053736
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses. If unsuccessful in the dispensed lenses, additional lenses may be trialed. Once vision and lens fit are determined to be acceptable, eligible subjects will wear study lenses in both eyes for at least 8 hours per day (with the exception of the follow-up visits where the lenses should be worn for a minimum of 2 hours), for approximately 1 week (7 days +/-3 days). Measurements will be taken at the insertion visit and at the 7-day follow-up visit.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  1. Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
  2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
  3. Have no active ocular disease or allergic conjunctivitis.
  4. Not be using any topical ocular medications.
  5. Be willing and able to follow instructions.
  6. Have signed a statement of informed consent
Read More
Exclusion Criteria
  1. Participating in a conflicting study in the opinion of the Investigator.
  2. Considered by the Investigator to not be a suitable candidate for participation.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
REVIVE™ Toric Soft Contact LensesREVIVE Contact Lens-
Primary Outcome Measures
NameTimeMethod
Mean logMAR Visual Acuity at 6mAt one week follow up

Mean logMAR Visual Acuity at 6m

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bausch & Lomb, Incorporated

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath